Coronavirus Elimination 4 9 5 6 5 7 7 8 5 5 7 8 6 2

Engineer come expert dowser, Lloyd Mear, ​

has spent most of his life working with frequencies. ​

He has just published a frequency number​

for the coronavirus.​

A body which holds this frequency is immune.​

 

SourceURL:https://www.thesun.co.uk/news/10784...um=social&utm_campaign=sharebarwebCoronavirus

death toll hits 17 as cases of ‘mutating’ bug
DOUBLE to 440 in just 24 hours

• KILLER BUG

Coronavirus death toll DOUBLES to 17

as more than 600 cases of ‘mutating’ bug confirmed

• Lizzie Parry
• Tariq Tahir

• 22 Jan 2020, 7:35
• SEVENTEEN people have died from coronavirus as more than 600 cases

of the killer strain were confirmed, officials have said.

Latest figures reveal 471 coronavirus cases in China,

with four in Thailand, two in Hong Kong

and one each in the US, Taiwan,

South Korea and Japan.
<img src="https://www.cosmosdawn.net/attachments/nintchdbpict000556375201-jpg.54739/" title="NINTCHDBPICT000556375201." alt="NINTCHDBPICT000556375201." class="bbCodeImage LbImage" />
16
Passengers arrive into Heathrow on a flight from Wuhan, where the virus startedCredit: Ian Whittaker.
<img src="https://www.cosmosdawn.net/attachments/nintchdbpict000556375285-jpg.54740/" title="NINTCHDBPICT000556375285." alt="NINTCHDBPICT000556375285." class="bbCodeImage LbImage" />
16
Enhanced monitoring is in place for direct flights from Wuhan to the UKCredit: Ian Whittaker.
<img src="https://www.cosmosdawn.net/attachments/dd-composite-coronavirus-spread-map-22-jan-v2-jpg.54741/" title="DD-COMPOSITE-CORONAVIRUS-SPREAD-MAP-22-jan-v2." alt="DD-COMPOSITE-CORONAVIRUS-SPREAD-MAP-22-jan-v2." class="bbCodeImage LbImage" />
16
Seventeen people have died from coronavirus and more than 470 cases of the killer strain have been confirmed in China alone
<img src="https://www.cosmosdawn.net/attachments/nintchdbpict000556283548-jpg.54742/" title="NINTCHDBPICT000556283548." alt="NINTCHDBPICT000556283548." class="bbCodeImage LbImage" />
16
A Chinese hospital has released first pictures of doctors treating patients who have been struck down by a new deadly virusCredit: Wuhan Central Hospital/Weibo
<img src="https://www.cosmosdawn.net/attachments/nintchdbpict000556283544-jpg.54743/" title="NINTCHDBPICT000556283544." alt="NINTCHDBPICT000556283544." class="bbCodeImage LbImage" />
16
Staff at Central Hospital of Wuhan were pictured with clenched fistsCredit: Wuhan Central Hospital/Weibo

There is also unconfirmed reports of a case in Mexico.
It comes as British experts said up to 10,000 people could already be infected

• adding that we can't rule out the possibility"
• there could already be a case in the UK.

Professor Neil Ferguson, an expert at Imperial College London,
said the new strain is currently "as deadly as the Spanish flu epidemic".
The 1918 outbreak is the most severe pandemic in recent history,
wiping out an estimated 50 million people across the world.

Prof Ferguson warned of "more deaths to come" as fellow experts
said the outbreak has reached the threshold for an international public health emergency
- ahead of today's World Health Organization meeting on the issue.
The agency could declare the virus a global health crisis today
as its experts rallied to hold an emergency meeting in Geneva today.
'THOUSANDS COULD BE INFECTED'

Officials are considering putting Wuhan - a city of 11 million,
a larger population than London - on lockdown,
with people being told to stop travelling and to avoid crowds.
It comes at one of the busiest times of the year in China
as people prepare to celebrate the Lunar New Year holidays.

The '2019-nCoV' strain has spread to other countries and major cities including Beijing,
Shanghai and southern Guangdong province.
Taiwan and the US were the latest countries to confirm a case of the lethal SARS
-like virus
- after Australian officials said a man tested amid fears he picked up the bug in China was clear.

The new strain has also hit South Korea, Japan, Thailand, Hong Kong,
Macau with the World Health Organization predicting it will continue to cross international borders in the coming days.
It comes as Chinese officials confirmed 'novel coronavirus' - which causes pneumonia - can be passed from person to person.
16
The patient being taken inside the hospital by a hazmat wearing medic
16
Thai medical staff transferring a Thai 70-year-old patient, who is suspected of being coronavirus infected after traveling back from China's WuhanCredit: EPA
16
A nurse checks a patient's body temperature next to a campaign poster alerting on the coronavirus at a hospital in Bangkok, ThailandCredit: EPA
16
Paramilitary police at Hongqiao station in ShanghaiCredit: EPA
Chinese officials confirmed 471 known cases earlier today, adding another 2,197 people are in isolation after coming into contact with infected people.
So far 765 of those have been released from observation, Li Bin said, adding there is mounting evidence that the bug is being spread through "respiratory transmission".
Li said: "Recently there has been a big change in the number of cases, which is related to our deepening our understanding of the disease, improving diagnostic methods and optimising the distribution of diagnostic kits."
Fifteen healthcare professionals are among those infected.
16
Officials last night stepped up checks at Heathrow as the death toll doubled in a day to 17Credit: Ian Whittaker.
16
Health officials watch travellers on a thermographic monitor at the Kuala Lumpur International Airport in MalaysiaCredit: AP:Associated Press
16
The airport checks were put in place after it was revealed the virus had jumped bordersCredit: AP:Associated Press
16
Chinese people wear masks in the street of the capital BeijingCredit: EPA
The mayor of Wuhan confirmed yesterday that an 89-year-old man from the city had become the fourth victim.
A 66-year-old man, known only as Li, and a woman, 48, known as Yin were also confirmed to have died from multiple organ failure.
In Taiwan yesterday, an epidemic response command centre has been set up with more than 1,000 beds prepared in isolation wards in case the virus spreads further.
There, health officials confirmed a woman, thought to be in her 50s, had caught the new strain.
She is currently in hospital and receiving treatment, according to local media reports.
So far, the WHO has not advised travel or trade restrictions but could put such measures in place at tomorrow's emergency meeting.
TRAVEL THREAT

It comes as China faces its busiest travel period over Chinese New Year - a time when millions board trains and planes to celebrate the Lunar New Year holidays.
Speaking on LBC leading virologist Professor John Oxford, from Queen Mary College, said he was "quaking in my shoes" at the potential for spread over the holidays.
He said: "None of us have faced a new virus with so many people in a community travelling around.
"That's what's going to happen in China at the end of the week.
"Once they are close together in taxis or small rooms, then there may be a problem.
"The only way to stop it is physical cleaning and social distance - keeping away from people."
While NHS chiefs have urged doctors in the UK to be alert to signs of the killer virus, and screening is due to begin at Heathrow airport, they said today the threat to Brits is "low".
GLOBAL AIRPORT SCREENING

At least half a dozen Asian countries and three US airports have started screening incoming airline passengers from central China.
In Australia, border forces have been ordered to ensure all sick passengers are assessed by a trained Biosecurity officer on arrival.
Chief health officer Brendan Murphy said the risk was low but added the three daily flights from Wuhan will be met by medics in response to the "rapidly emerging situation".
State health officials in New South Wales are distributing pamphlets in English and Chinese to all passengers arriving from Wuhan describing the symptoms.
16
Passengers at Hongqiao Railway Station in Shanghai wearing masks as peak spring festival travel period gets underwayCredit: EPA
16
Health officials wear face masks at an inspection at Kuala Lumpur International AirportCredit: AP:Associated Press
16
A traveller wears a face mask as he sits in a waiting room at the Beijing West Railway StationCredit: AP:Associated Press
The US has also started screening passengers on flights from Wuhan arriving at John F. Kennedy International Airport, San Francisco International Airport and Los Angeles International airport.
Other international airports are also screening passengers for the mysterious SARS-like disease after it was revealed it had jumped China’s borders.
A video has been shared widely on Twitter showing people on a domestic flight out of the central Chinese city of Wuhan having their temperature taken one-by-one by people in protective suits.
The origin of the virus is not get known, but experts say the most likely source is an animal - with a new study suggesting bats might be the primary source.
Chinese officials have linked the outbreak last month to a seafood market in the city of Wuhan.
The new strain belongs to a large family of viruses that cause illnesses ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS).
ANIMAL SOURCE

The common early signs of infection include fever, cough, shortness of breath and breathing difficulties, according to WHO.
In more severe cases, it can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death.
Initial symptoms of the novel coronavirus include fever, cough, tightness of the chest and shortness of breath, and those seriously ill developed pneumonia.

MORE ON THE VIRUS


DEADLY DELICACY

What is bat soup, is it safe to eat and how is it linked to coronavirus?



CORONA COMING

UK threat of coronavirus is RISING despite fury over lack of airport checks


HIGH ALERT

Cops put two police stations on lockdown in Bristol after coronavirus scare


Latest

‘A LITTLE TOO LATE’

Chinese revolt on Weibo over government's response to virus outbreak


HIGH ALERT

Is it safe to travel to China? Latest advice as coronavirus triggers lockdown



LIKE A BAT OUTTA HELL

Fears coronavirus outbreak is linked to bat soup sold at Wuhan market



VIRUS FEARS

Is coronavirus coming to the UK? Risk changed from 'very low' to 'low'


Breaking

HIGH ALERT

Four people in UK hospital with suspected coronavirus after flying from China



WORLD WAR FLU

Deadly coronavirus could ALREADY be in UK after killing 17 & infecting 10,000



LIVING COFFIN

Coronavirus patient is sealed in a PLASTIC TUBE to avoid contaminating others




A Brit on holiday in Thailand is feared to be the first western victim of the illness.
Ash Shorley, 32, was rushed to hospital after the bug infected both lungs while he was on Koh Phi Phi island in Thailand.
The outbreak has caused alarm because of its connection to Severe Acute Respiratory Syndrome (SARS), which killed nearly 650 people across mainland China and Hong Kong in 2002-2003.
Coronaviruses cause diseases ranging from the common cold to more severe ones such as SARS.
The Chinese government initially tried to conceal the severity of that epidemic but its cover-up was exposed by a high-ranking physician.
What is coronavirus?
Coronavirus is an airborne virus, spread in a similar way to colds and the flu.
The virus attacks the respiratory system, causing lung lesions.
Symptoms include a runny nose, headache, cough and fever, shortness of breath, chills and body aches.
It is incredibly contagious and is spread through contact with anything the virus is on as well as infected breath, coughs or sneezes.
Symptoms include a runny nose, headache, cough and fever, shortness of breath, chills and body aches.
In most cases, you won't know whether you have a coronavirus or a different cold-causing virus, such as rhinovirus.
But if a coronavirus infection spreads to the lower respiratory tract (your windpipe and your lungs), it can cause pneumonia, especially in older people, people with heart disease or people with weakened immune systems.
There is no vaccine for coronavirus.
In 2003 an outbreak of a similar virus, SARS, infected more than 8,000 people in 37 countries before it was brought under control, killing 800 of those worldwide.
First footage shows Wuhan doctors in hazmat suits treating patients with coronavirus infection in China

• https://www.thesun.co.uk/news/10784...dium=social&utm_campaign=sharebarweb[/bcolor]
  

 

Version:1.0 StartHTML:000000281 EndHTML:000086485 StartFragment:000040933 EndFragment:000086382 StartSelection:000040962 EndSelection:000086366 SourceURL:https://usahitman.com/coronavirus-p...M0EBkgWpSdK29IEAmdsi3alNUYyr6gMpal44pDC339Z7s CORONAVIRUS is a Patented Virus - USAHITMAN Conspiracy News &lt;style&gt; .wpb_animate_when_almost_visible { opacity: 1; }&lt;/style&gt;
CORONAVIRUS is a Patented Virus

• January 22, 2020
• 18422

Below is a quick list of patents which deal with this ‘new’ coronavirus. Well there is a pretty recent patent as of July 4th, 2019 with this coronavirus. We know how most of these viruses are lab created and this provides some more reach or information to research!

• CORONAVIRUS PROTEINS AND ANTIGENS Publication number: 20160339097 Abstract: Disclosed herein are embodiments of a method for collecting, extracting or eluting proteins and antigens from cells infected with coronavirus. The coronavirus may be a porcine coronavirus, such as porcine epidemic diarrhea virus (PEDV) or porcine delta coronavirus (PDCoV). Also disclosed are embodiments of a composition comprising the coronavirus proteins and antigens, and embodiments of a method of using such a composition. Applications for the composition include, but are not limited to, use in the preparation of antibodies against the proteins and antigens, use as reference markers for coronavirus proteins, and/or use in an immunogenic composition, such as in a vaccine composition. Type: Application Filed: August 4, 2016 Publication date: November 24, 2016 Applicant: MJ Biologics, Inc. Inventor: Byoung-Kwan Kim
• CORONAVIRUS PROTEINS AND ANTIGENS Publication number: 20190202868 Abstract: Disclosed herein are embodiments of a method for collecting, extracting or eluting proteins and antigens from cells infected with coronavirus. The coronavirus may be a porcine coronavirus, such as porcine epidemic diarrhea virus (PEDV) or porcine delta coronavirus (PDCoV). Also disclosed are embodiments of a composition comprising the coronavirus proteins and antigens, and embodiments of a method of using such a composition. Applications for the composition include, but are not limited to, use in the preparation of antibodies against the proteins and antigens, use as reference markers for coronavirus proteins, and/or use in an immunogenic composition, such as in a vaccine composition. Type: Application Filed: March 15, 2019 Publication date: July 4, 2019 Applicant: Phibro Animal Health Corporation Inventor: Byoung-Kwan Kim
• Coronavirus proteins and antigens Patent number: 10280199 Abstract: Disclosed herein are embodiments of a method for collecting, extracting or eluting proteins and antigens from cells infected with coronavirus. The coronavirus may be a porcine coronavirus, such as porcine epidemic diarrhea virus (PEDV) or porcine delta coronavirus (PDCoV). Also disclosed are embodiments of a composition comprising the coronavirus proteins and antigens, and embodiments of a method of using such a composition. Applications for the composition include, but are not limited to, use in the preparation of antibodies against the proteins and antigens, use as reference markers for coronavirus proteins, and/or use in an immunogenic composition, such as in a vaccine composition. Type: Grant Filed: August 4, 2016 Date of Patent: May 7, 2019 Assignee: Phibro Animal Health Corporation Inventor: Byoung-Kwan Kim
• Vaccine compositions and methods of treating coronavirus infection Publication number: 20060286124 Abstract: The present disclosure relates to compositions and methods for treating or preventing coronavirus infections. For example, compositions are provided that comprise a coronavirus S protein or N protein, fragment, or variant thereof, capable of eliciting a protective humoral and/or cell-mediated immune response, which compositions are useful for treating or preventing infection by coronavirus, such as the causative agent of SARS. Also, coronavirus S protein and N protein immunogen compositions are provided that include an adjuvant, such as Proteosome or Protollin, which may be used for treating or preventing infection caused by a coronavirus, such as a SARS coronavirus. Type: Application Filed: June 30, 2005 Publication date: December 21, 2006 Applicant: ID Biomedical Corporation of Quebec Inventors: David Burt, Mark Reddish, Mary Hu, George Lowell, David Jones
• Uncharacterized ORF3 in SARS-coronavirus is a cyclic-AMP-dependent kinase and a target for SARS therapy Publication number: 20050276818 Abstract: The present invention relates to novel methods for identifying antiviral agents which selectively interfere with viral proteins that cause the unique infectivity activity of the SARS-coronavirus in comparison to other non-SARS strains of coronavirus. In particular, the present invention relates to screening assays that identify agents which selectively inhibit cyclic-AMP dependent protein kinase activity of the SARS-coronavirus ORF3. The present invention also relates to screening assays that identify agents which selectively inhibit the interaction between SARS-coronavirus cyclic-AMP dependent protein kinase and a calcium dependent targeting molecule. Therefore the agents identified using the assays of the invention may have utility as antiviral agents. The present invention also relates to treatments for sever acute respiratory syndrome caused by a coronavirus, and particularly to treatments that affect the infectivity activity of the SARS-coronavirus. Type: Application Filed: May 17, 2005 Publication date: December 15, 2005 Inventors: Adam Godzik, Sergey Sikora
• Uncharacterized ORF3 in SARS-coronavirus is a cyclic-AMP-dependent kinase and a target for SARS therapy Patent number: 7504205 Abstract: The present invention relates to novel methods for identifying antiviral agents which selectively interfere with viral proteins that cause the unique infectivity activity of the SARS-coronavirus in comparison to other non-SARS strains of coronavirus. In particular, the present invention relates to screening assays that identify agents which selectively inhibit cyclic-AMP dependent protein kinase activity of the SARS-coronavirus ORF3. The present invention also relates to screening assays that identify agents which selectively inhibit the interaction between SARS-coronavirus cyclic-AMP dependent protein kinase and a calcium dependent targeting molecule. Therefore the agents identified using the assays of the invention may have utility as antiviral agents. The present invention also relates to treatments for sever acute respiratory syndrome caused by a coronavirus, and particularly to treatments that affect the infectivity activity of the SARS-coronavirus. Type: Grant Filed: May 17, 2005 Date of Patent: March 17, 2009 Assignee: The Burnham Institute Inventors: Adam Godzik, Sergey Sikora
• Inactivated canine coronavirus vaccine Patent number: 4567042 Abstract: An efficacious parenterally administered inactivated canine coronavirus vaccine which provides systemic, humoral protection and also protection of the intestinal tract in dogs from infection by virulent canine coronavirus is produced. A method for propagation of the canine coronavirus and its attenuation and a method of evaluating the effectiveness of a canine coronavirus vaccine in canines is also disclosed. Type: Grant Filed: June 7, 1984 Date of Patent: January 28, 1986 Assignee: American Home Products Corporation Inventors: William M. Acree, Bobby Edwards, John W. Black
• CANINE RESPIRATORY CORONAVIRUS (CRCV) SPIKE PROTEIN, POLYMERASE AND HEMAGGLUTININ/ESTERASE Publication number: 20090081780 Abstract: A canine respiratory coronavirus (CRCV) that is present in the respiratory tract of dogs with canine infectious respiratory disease and which has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (e.g., Quebec and LY138) and human coronavirus strain OC43. Type: Application Filed: September 26, 2008 Publication date: March 26, 2009 Applicant: The Royal Veterinary College Inventors: John Brownlie, Victoria Jane Chalker, Kerstin Erles
• PEPTIDE COMPOUNDS FOR DETECTING OR INHIBITING SARS CORONAVIRUS AND APPLICATION THEREOF Publication number: 20100304363 Abstract: Disclosed herein are peptide compounds and the application thereof to the detection and inhibition of SARS coronavirus. Composed of dipeptides, the compounds for detecting and inhibiting SARS coronavirus can be readily synthesized and produced at low cost. In addition, they can be stored safely for a long period of time. The dipeptide compounds are useful as inhibitors of SARS coronavirus as well as acting as excellent capturing materials of SARS coronavirus. Type: Application Filed: May 26, 2010 Publication date: December 2, 2010 Applicant: ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE Inventors: Soo-Hyung LEE, Hyo-Bong Hong, Tao-Wan Kim, Myung-Ae Chung, Sung-Woo Sohn, Seoung-Min Yoo
• Canine Respiratory Coronavirus (Crcv) Spike Protein, Polymerase and Hemagglutinin/Esterase Publication number: 20070248616 Abstract: A canine respiratory coronavirus (CRCV) that is present in the respiratory tract of dogs with canine infectious respiratory disease and which has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (e.g. Quebec and LY138) and human coronavirus strain OC43. The CRCV spike, polymerase and hemagglutinin/esterase cDNA and protein partial sequences are listed in FIGS. (1) to (4), (13) and (14). Type: Application Filed: July 1, 2003 Publication date: October 25, 2007 Inventors: John Brownlie, Victoria Chalker, Kerstin Erles
• Canine respiratory coronavirus (CRCV) spike protein Patent number: 7981427 Abstract: A canine respiratory coronavirus (CRCV) that is present in the respiratory tract of dogs with canine infectious respiratory disease and which has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (e.g., Quebec and LY138) and human coronavirus strain OC43. Type: Grant Filed: September 26, 2008 Date of Patent: July 19, 2011 Assignee: The Royal Veterinary College Inventors: John Brownlie, Victoria Jane Chalker, Kerstin Erles
• Methods and compositions for infectious cDNA of SARS coronavirus Publication number: 20060240530 Abstract: The present invention provides a cDNA of a severe acute respiratory syndrome (SARS) coronavirus, recombinant SARS coronavirus vectors, and SARS coronavirus replicon particles. Also provided are methods of making the compositions of this invention and methods of using the compositions as immunogens and/or vaccines and/or to express heterologous nucleic acids. Type: Application Filed: January 19, 2006 Publication date: October 26, 2006 Inventors: Ralph Baric, Rhonda Roberts, Boyd Yount, Kristopher Curtis
• Compositions and methods for detecting severe acute respiratory syndrome coronavirus Publication number: 20050095582 Abstract: The invention provides compositions and methods for detecting the presence of SARS-coronavirus, for screening anti-SARS coronavirus agents and vaccines, and for reducing infection with plus-strand RNA viruses such as SARS-coronavirus. Type: Application Filed: November 3, 2003 Publication date: May 5, 2005 Applicants: Diagnostic Hybrids, Inc., Health Research Incorporated Inventors: Laura Gillim-Ross, Jill Taylor, David Scholl, David Wentworth, Joseph Jollick Compositions and Methods for Detecting Severe Acute Respiratory Syndrome Coronavirus Publication number: 20080076115 Abstract: The invention provides compositions and methods for detecting the presence of SARS-coronavirus, for screening anti-SARS coronavirus agents and vaccines, and for reducing infection with plus-strand RNA viruses such as SARS-coronavirus. Type: Application Filed: November 3, 2004 Publication date: March 27, 2008 Inventors: David R. Scholl, Joseph D. Jollick, Laura Gillim-Ross, Jill Taylor, David E. Wentworth
• Compositions And Methods For Detecting Severe Acute Respiratory Syndrome Coronavirus Publication number: 20110223659 Abstract: The invention provides compositions and methods for detecting the presence of SARS-coronavirus, for screening anti-SARS coronavirus agents and vaccines, and for reducing infection with plus-strand RNA viruses such as SARS-coronavirus. Type: Application Filed: December 7, 2010 Publication date: September 15, 2011 Inventors: David R. Scholl, Joseph D. Jollick, Laura Gillim-Ross, Jill Taylor, David E. Wentworth
• Ribozyme to cleave coronavirus gene Publication number: 20100273997 Abstract: Provided is a ribozyme to cleave a coronavirus gene and a therapeutic agent for a coronavirus infectious disease. A common base sequence in coronaviruses such as SARS-CoV and MHV was searched to design a ribozyme including a base sequence complementary thereto. Moreover, a therapeutic agent for a coronavirus infectious disease including such ribozyme was obtained. Type: Application Filed: August 9, 2006 Publication date: October 28, 2010 Inventors: Noboru Fukuda, Takahiro Ueno, Akiko Fukushima, Kazumichi Kuroda
• Compositions and methods for treating coronavirus infection and SARS Publication number: 20050002901 Abstract: The present invention provides methods of treating a coronavirus infection, and methods of reducing viral load, or reducing the time to viral clearance, or reducing morbidity or mortality in the clinical outcomes, in patients suffering from a coronavirus infection. The present invention further provides methods of reducing the risk that an individual will develop a pathological coronavirus infection, that has clinical sequelae. The present invention further provides methods of reducing the risk that an individual will develop SARS. The present invention further provides methods of treating SARS. The methods generally involve administering a therapeutically effective amount of a Type I or Type III interferon receptor agonist and/or a Type II interferon receptor agonist for the treatment of a coronavirus infection. Type: Application Filed: March 30, 2004 Publication date: January 6, 2005 Inventor: Lawrence Blatt
• FUSION PROTEINS OF RECOMBINANT SARS CORONAVIRUS STRUCTURAL PROTEINS, THEIR PRODUCTION AND USES Publication number: 20100150923 Abstract: Fusion proteins of recombinant SARS coronavirus structural proteins, their production and uses are provided. An optimized SARS coronavirus S protein gene which can be highly expressed in the mammalian cell strains and SARS coronavirus S protein variants comprising deletion, modification or mutation amino acids 318-510 corresponding to SARS coronavirus S protein are also provided. Type: Application Filed: June 13, 2006 Publication date: June 17, 2010 Applicant: Chinese Academy of Medical Sciences, Institute of Basic Medical Sciences Inventors: Chengyu Jiang, Feng Guo, Shuan Rao, Bing Guan, Yi Huan, Peng Yang
• Civet animal model system for Severe Acute Respiratory Syndrome (SARS) coronavirus infection and uses thereof Publication number: 20060123499 Abstract: The present invention is directed towards the use of the masked palm civet Paguma larvata (“civet”) as an animal model system for SARS, and is based on the novel demonstration of the present invention that civets may be infected with exogenous coronavirus, and that such infection produces SARS-like symptoms in these infected animals. The present invention is directed to a civet model system for the study of the infection, replication, and clinical effects of exogenously introduced human SARS-CoV coronavirus strains, civet SARS-CoV-like coronavirus strains, or variants or derivatives thereof, and to the development of vaccines (or other methods of prevention) or treatment of infection or transmission to other civets or humans of these human SARS-CoV coronavirus strains, civet SARS-CoV-like coronavirus strains, or variants or derivatives thereof. Type: Application Filed: December 6, 2004 Publication date: June 8, 2006 Inventors: Donglai Wu, Xiangang Kong, Qingwen Meng, Yonggang Liu, Yuntao Guan, Xunnan Yin, Mouping Wang, Changwen Li, Ming Liao, Chao-an Xin, Jinding Chen, Changchun Tu, Hua Xuan, Yedong Yu
• METHODS AND COMPOSITIONS FOR CORONAVIRUS DIAGNOSTICS AND THERAPEUTICS Publication number: 20160238601 Abstract: The present invention provides methods and compositions for detecting a coronavirus in a sample and identifying the subgroup of the coronavirus in the sample. Type: Application Filed: October 14, 2014 Publication date: August 18, 2016 Inventors: Ralph Baric, Sudhakar Agnihothram, Boyd Yount

 

post 4 from https://usahitman.com/coronavirus-p...rDx4vyOTdTMaG3WceHLmqWwyz9BmJjxJ13K0[/bcolor]

 

is the new 'deadly china virus' a covert operation ????

https://www.wakingtimes.com/2020/01...uVW0tw6jP7p8yCj9V6N-YeQqp6ZVziugEm-8[/bcolor]

 

Waking Times
NEW VIRUS IN CHINA. WATCH OUT. SPREADING.
ANIMALS TO HUMANS?
PANDEMIC COMING UP?
OBEY MEDICAL AUTHORITIES.
ALL HANDS ON DECK.
CENTERED IN WUHAN.
CITY OF 11 MILLION.
WILL THEY QUARANTINE AND SHUT DOWN HONG KONG?
TRAVELERS WITH THE VIRUS GETTING THROUGH TO EUROPE
AND AMERICA? WHAT’S THE NAME OF THE VIRUS?
2019-nCOV or nCoV2019.
WHAT? THANK GOD THE CHINESE ARE UNDER A TIGHT DICTATORSHIP,
THEY CAN CRACK DOWN AND QUARANTINE ANYBODY ON A WHIM.
IF YOUR BODY TEMPERATURE IS ELEVATED ON A TEST,
THEY STOP YOU?
WOW. WE MAY NEED THAT IN THE USA,
AS LONG AS THEY DON’T STOP ME. IMPEACHMENT?
FORGET THAT, IT’S THE VIRUS.
In the 19 years of this website,
the one story I’ve researched and covered more
than any other is the DEADLY VIRUS hustle.
SARS, Swine Flu, Ebola, etc.
Now, we have a new one. The possible maybe CORONAVIRUS from China.
In each case of these could-be killers, we have an official warning.

“This could be the big one.” Millions of people could fall ill and die.

In each case, there are travelers. “People returning from X have the virus
and they are spreading it.”

In the case of SARS and Swine Flu, the patients’ symptoms
were typical “flu” symptoms: fever, fatigue, cough, weakness.

In other words, there was no reason to think the “new disease”
was any different from ordinary traditional illness.

The big and only difference is the claim that researchers
have found a new virus as the cause of illness.
But in each case, there are serious problems with that claim.
First, only “official researchers” are involved with the “discovery” of the new virus.

There is no confirmation from independent researchers.

For example, in the case of SARS (2003),
ten labs belonging to the World Health Organization (WHO)
performed the “discovery” of that coronavirus.

They were connected through closed circuit—no outsiders allowed.
Eventually, a Canadian biologist working for WHO, Frank Plummer,
told the press he was quite puzzled by what he was seeing:
more and more SARS patients didn’t have the SARS virus at all.
In fact, almost no new SARS patients had the virus.

Well, when you stop and think about that ridiculous state of affairs,
you realize you can’t say a person, with ordinary flu-like symptoms,
is suffering from a new disease if he doesn’t have the cause of that disease.

But the mainstream press took no notice of this and moved on.

In the case of the Swine Flu “epidemic” (2009),
the US Centers for Disease Control (CDC) was reporting thousands of cases in America
—but CBS star reporter Sharyl Attkisson found out that the CDC had,
mysteriously, stopped counting cases.

How could this be? She came up with the devastating answer.

The overwhelming percentage of blood tests on Swine Flu patients
were coming back from labs with no sign of the Swine Flu virus
or any other flu virus.

That story ran on the CBS News site, but as Attkisson told me in an interview,
the bosses at CBS wouldn’t allow it on the national television news broadcast.
Censored.

And that was the end of the CBS exposure of the Swine Flu hoax.

Yet, as I reported: about three weeks after CBS shut down the story,
WebMD ran a piece in which the CDC
estimated there were 22 MILLION cases of Swine Flu in the US.

If your head is spinning, it should be.​

​

The second major problem with the announcement
of a “new disease” or an epidemic is the absence
of research on what we could call the “infection factor.”

Let me explain.

To even begin to say a particular germ is causing a particular disease,
you have to prove the germ is present in a patient’s body
IN GREAT NUMBERS.

A few little viral particles floating around here
and there are irrelevant. You need millions.

So if an ignorant doctor or a researcher states,
“Well, this patient has the coronavirus so he has the disease,”
he’s falling far short of proving anything useful.

Where are the tests proving the patient has millions of the virus in his body?

Nowhere.


The third major problem with the announcement of a “new disease”
or an epidemic is the “test factor.”
What test is being run on a patient to prove he has the “new virus” in his body?
Most of the time, it is an antibody test. Stay with me here, this is important.
Prior to 1984, it was generally recognized that a positive antibody test
was a good outcome.

In short, it indicated that the patient’s immune system
had come in contact with a germ and successfully defeated it.

But then, for several reasons, this science was turned on its head.

A positive antibody test, from that time on,
was evidence that the patient currently had the disease in question.

Boom.

Now, disease numbers could easily be inflated.

And they were.
And they are.
Automatically assuming that the announcement
of a possible epidemic is accurate
—well, it’s a major mistake, to say the least.
The CDC and WHO are operated by virus hunters.
Running a new virus up the flagpole is their stock in trade.
They rush to an area where an “outbreak” has been announced,
and they roll up their sleeves and look for the virus.
They pay no attention to environmental factors,
such as contaminated water supplies or toxic chemicals
or malnutrition or lack of basic sanitation.
Epidemics are good for business. Pharmaceutical business,
inducing fear business, shutting down travel business,
diverting the public from key events business, surveillance
and quarantine business, and so on.
I’m sure, at some point,
there will be THANK YOU, CHINA, BUSINESS, too.
Thank you, China, for your rule by iron fist over the population.
Your ability to stop anyone for any reason and test for “the virus”
may have saved the planet from an extinction event.
Freedom?
Forget it.
Public safety is the ace in the deck.
It wins every time.
Hell, we may need a good epidemic in the US,
so we can exert more control over the unruly citizenry.
The doctor is king.
Do what he says.
Always.
How many vaccines are there now?
Take all of them.
Everyone must.
Nineteen years ago, when I started this website,
I told you that, of all the cartels in this world,
the most important and powerful one, long-term,
was the medical cartel.
Nothing since that time has changed my mind.

Jon Rappoport​

https://blog.nomorefakenews.com/2020/01/22/is-the-new-deadly-china-virus-a-covert-operation/​

 

Is Coronavirus A Manmade Depopulation Weapon?​

https://banned.video/watch?id=5e290...OBniIfiMactkh28TxwAs_0eqlxwY97IjMB8g[/bcolor]

 

CORONAVIRUS is a Patented Virus
January 22, 2020
37794
Below is a quick list of patents which deal with this ‘new’ coronavirus.

Well there is a pretty recent patent as of July 4th, 2019 with this coronavirus.

We know how most of these viruses are lab created and this provides some more reach or information to research!

CORONAVIRUS PROTEINS AND ANTIGENS Publication number: 20160339097

Abstract: Disclosed herein are embodiments of a method for collecting, extracting or eluting proteins and antigens from cells infected with coronavirus. The coronavirus may be a porcine coronavirus, such as porcine epidemic diarrhea virus (PEDV) or porcine delta coronavirus (PDCoV). Also disclosed are embodiments of a composition comprising the coronavirus proteins and antigens, and embodiments of a method of using such a composition. Applications for the composition include, but are not limited to, use in the preparation of antibodies against the proteins and antigens, use as reference markers for coronavirus proteins, and/or use in an immunogenic composition, such as in a vaccine composition. Type: Application Filed: August 4, 2016 Publication date: November 24, 2016
Applicant: MJ Biologics, Inc.
Inventor: Byoung-Kwan Kim

CORONAVIRUS PROTEINS AND ANTIGENS Publication number: 20190202868 Abstract: Disclosed herein are embodiments of a method for collecting, extracting or eluting proteins and antigens from cells infected with coronavirus. The coronavirus may be a porcine coronavirus, such as porcine epidemic diarrhea virus (PEDV) or porcine delta coronavirus (PDCoV). Also disclosed are embodiments of a composition comprising the coronavirus proteins and antigens, and embodiments of a method of using such a composition. Applications for the composition include, but are not limited to, use in the preparation of antibodies against the proteins and antigens, use as reference markers for coronavirus proteins, and/or use in an immunogenic composition, such as in a vaccine composition.
Type: Application Filed: March 15, 2019 Publication date: July 4, 2019 Applicant: Phibro Animal Health Corporation
Inventor: Byoung-Kwan Kim

Coronavirus proteins and antigens Patent number: 10280199 Abstract: Disclosed herein are embodiments of a method for collecting, extracting or eluting proteins and antigens from cells infected with coronavirus. The coronavirus may be a porcine coronavirus, such as porcine epidemic diarrhea virus (PEDV) or porcine delta coronavirus (PDCoV). Also disclosed are embodiments of a composition comprising the coronavirus proteins and antigens, and embodiments of a method of using such a composition. Applications for the composition include, but are not limited to, use in the preparation of antibodies against the proteins and antigens, use as reference markers for coronavirus proteins, and/or use in an immunogenic composition, such as in a vaccine composition. Type: Grant Filed: August 4, 2016 Date of Patent: May 7, 2019
Assignee: Phibro Animal Health Corporation
Inventor: Byoung-Kwan Kim

Vaccine compositions and methods of treating coronavirus infection Publication number: 20060286124 Abstract: The present disclosure relates to compositions and methods for treating or preventing coronavirus infections. For example, compositions are provided that comprise a coronavirus S protein or N protein, fragment, or variant thereof, capable of eliciting a protective humoral and/or cell-mediated immune response, which compositions are useful for treating or preventing infection by coronavirus, such as the causative agent of SARS. Also, coronavirus S protein and N protein immunogen compositions are provided that include an adjuvant, such as Proteosome or Protollin, which may be used for treating or preventing infection caused by a coronavirus, such as a SARS coronavirus. Type: Application Filed: June 30, 2005 Publication date: December 21, 2006 Applicant: ID Biomedical Corporation of Quebec Inventors: David Burt, Mark Reddish, Mary Hu, George Lowell, David Jones
Uncharacterized ORF3 in SARS-coronavirus is a cyclic-AMP-dependent kinase and a target for SARS therapy Publication number: 20050276818 Abstract: The present invention relates to novel methods for identifying antiviral agents which selectively interfere with viral proteins that cause the unique infectivity activity of the SARS-coronavirus in comparison to other non-SARS strains of coronavirus. In particular, the present invention relates to screening assays that identify agents which selectively inhibit cyclic-AMP dependent protein kinase activity of the SARS-coronavirus ORF3. The present invention also relates to screening assays that identify agents which selectively inhibit the interaction between SARS-coronavirus cyclic-AMP dependent protein kinase and a calcium dependent targeting molecule. Therefore the agents identified using the assays of the invention may have utility as antiviral agents. The present invention also relates to treatments for sever acute respiratory syndrome caused by a coronavirus, and particularly to treatments that affect the infectivity activity of the SARS-coronavirus.
Type: Application Filed: May 17, 2005 Publication date: December 15, 2005
Inventors: Adam Godzik, Sergey Sikora

Uncharacterized ORF3 in SARS-coronavirus is a cyclic-AMP-dependent kinase and a target for SARS therapy Patent number: 7504205 Abstract: The present invention relates to novel methods for identifying antiviral agents which selectively interfere with viral proteins that cause the unique infectivity activity of the SARS-coronavirus in comparison to other non-SARS strains of coronavirus. In particular, the present invention relates to screening assays that identify agents which selectively inhibit cyclic-AMP dependent protein kinase activity of the SARS-coronavirus ORF3. The present invention also relates to screening assays that identify agents which selectively inhibit the interaction between SARS-coronavirus cyclic-AMP dependent protein kinase and a calcium dependent targeting molecule. Therefore the agents identified using the assays of the invention may have utility as antiviral agents. The present invention also relates to treatments for sever acute respiratory syndrome caused by a coronavirus, and particularly to treatments that affect the infectivity activity of the SARS-coronavirus. Type: Grant Filed: May 17, 2005 Date of Patent: March 17, 2009 Assignee: The Burnham Institute Inventors: Adam Godzik, Sergey Sikora

Inactivated canine coronavirus vaccine Patent number: 4567042 Abstract: An efficacious parenterally administered inactivated canine coronavirus vaccine which provides systemic, humoral protection and also protection of the intestinal tract in dogs from infection by virulent canine coronavirus is produced. A method for propagation of the canine coronavirus and its attenuation and a method of evaluating the effectiveness of a canine coronavirus vaccine in canines is also disclosed. Type: Grant Filed: June 7, 1984 Date of Patent: January 28, 1986 Assignee: American Home Products Corporation Inventors: William M. Acree, Bobby Edwards, John W. Black

CANINE RESPIRATORY CORONAVIRUS (CRCV) SPIKE PROTEIN, POLYMERASE AND HEMAGGLUTININ/ESTERASE Publication number: 20090081780 Abstract: A canine respiratory coronavirus (CRCV) that is present in the respiratory tract of dogs with canine infectious respiratory disease and which has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (e.g., Quebec and LY138) and human coronavirus strain OC43. Type: Application Filed: September 26, 2008 Publication date: March 26, 2009 Applicant: The Royal Veterinary College Inventors: John Brownlie, Victoria Jane Chalker, Kerstin Erles

PEPTIDE COMPOUNDS FOR DETECTING OR INHIBITING SARS CORONAVIRUS AND APPLICATION THEREOF Publication number: 20100304363 Abstract: Disclosed herein are peptide compounds and the application thereof to the detection and inhibition of SARS coronavirus. Composed of dipeptides, the compounds for detecting and inhibiting SARS coronavirus can be readily synthesized and produced at low cost. In addition, they can be stored safely for a long period of time. The dipeptide compounds are useful as inhibitors of SARS coronavirus as well as acting as excellent capturing materials of SARS coronavirus. Type: Application Filed: May 26, 2010 Publication date: December 2, 2010 Applicant: ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE
Inventors: Soo-Hyung LEE, Hyo-Bong Hong, Tao-Wan Kim, Myung-Ae Chung, Sung-Woo Sohn, Seoung-Min Yoo

Canine Respiratory Coronavirus (Crcv) Spike Protein, Polymerase and Hemagglutinin/Esterase Publication number: 20070248616 Abstract: A canine respiratory coronavirus (CRCV) that is present in the respiratory tract of dogs with canine infectious respiratory disease and which has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (e.g. Quebec and LY138) and human coronavirus strain OC43. The CRCV spike, polymerase and hemagglutinin/esterase cDNA and protein partial sequences are listed in FIGS. (1) to (4), (13) and (14). Type: Application Filed: July 1, 2003 Publication date: October 25, 2007
Inventors: John Brownlie, Victoria Chalker, Kerstin Erles

Canine respiratory coronavirus (CRCV) spike protein Patent number: 7981427 Abstract: A canine respiratory coronavirus (CRCV) that is present in the respiratory tract of dogs with canine infectious respiratory disease and which has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (e.g., Quebec and LY138) and human coronavirus strain OC43. Type: Grant Filed: September 26, 2008 Date of Patent: July 19, 2011 Assignee: The Royal Veterinary College
Inventors: John Brownlie, Victoria Jane Chalker, Kerstin Erles

Methods and compositions for infectious cDNA of SARS coronavirus Publication number: 20060240530 Abstract: The present invention provides a cDNA of a severe acute respiratory syndrome (SARS) coronavirus, recombinant SARS coronavirus vectors, and SARS coronavirus replicon particles. Also provided are methods of making the compositions of this invention and methods of using the compositions as immunogens and/or vaccines and/or to express heterologous nucleic acids. Type: Application Filed: January 19, 2006 Publication date: October 26, 2006
Inventors: Ralph Baric, Rhonda Roberts, Boyd Yount, Kristopher Curtis

Compositions and methods for detecting severe acute respiratory syndrome coronavirus Publication number: 20050095582 Abstract: The invention provides compositions and methods for detecting the presence of SARS-coronavirus, for screening anti-SARS coronavirus agents and vaccines, and for reducing infection with plus-strand RNA viruses such as SARS-coronavirus. Type: Application Filed: November 3, 2003 Publication date: May 5, 2005 Applicants: Diagnostic Hybrids, Inc.,
Health Research Incorporated Inventors: Laura Gillim-Ross, Jill Taylor, David Scholl, David Wentworth, Joseph Jollick

Compositions and Methods for Detecting Severe Acute Respiratory Syndrome Coronavirus Publication number: 20080076115
Abstract: The invention provides compositions and methods for detecting the presence of SARS-coronavirus, for screening anti-SARS coronavirus agents and vaccines, and for reducing infection with plus-strand RNA viruses such as SARS-coronavirus.
Type: Application Filed: November 3, 2004 Publication date: March 27, 2008
Inventors: David R. Scholl, Joseph D. Jollick, Laura Gillim-Ross, Jill Taylor, David E. Wentworth

Compositions And Methods For Detecting Severe Acute Respiratory Syndrome Coronavirus Publication number: 20110223659 Abstract: The invention provides compositions and methods for detecting the presence of SARS-coronavirus, for screening anti-SARS coronavirus agents and vaccines, and for reducing infection with plus-strand RNA viruses such as SARS-coronavirus. Type: Application Filed: December 7, 2010 Publication date: September 15, 2011 Inventors: David R. Scholl, Joseph D. Jollick, Laura Gillim-Ross, Jill Taylor, David E. Wentworth
Ribozyme to cleave coronavirus gene Publication number: 20100273997 Abstract: Provided is a ribozyme to cleave a coronavirus gene and a therapeutic agent for a coronavirus infectious disease. A common base sequence in coronaviruses such as SARS-CoV and MHV was searched to design a ribozyme including a base sequence complementary thereto. Moreover, a therapeutic agent for a coronavirus infectious disease including such ribozyme was obtained. Type: Application Filed: August 9, 2006 Publication date: October 28, 2010
Inventors: Noboru Fukuda, Takahiro Ueno, Akiko Fukushima, Kazumichi Kuroda

Compositions and methods for treating coronavirus infection and SARS Publication number: 20050002901 Abstract: The present invention provides methods of treating a coronavirus infection, and methods of reducing viral load, or reducing the time to viral clearance, or reducing morbidity or mortality in the clinical outcomes, in patients suffering from a coronavirus infection. The present invention further provides methods of reducing the risk that an individual will develop a pathological coronavirus infection, that has clinical sequelae. The present invention further provides methods of reducing the risk that an individual will develop SARS. The present invention further provides methods of treating SARS. The methods generally involve administering a therapeutically effective amount of a Type I or Type III interferon receptor agonist and/or a Type II interferon receptor agonist for the treatment of a coronavirus infection. Type: Application Filed: March 30, 2004 Publication date: January 6, 2005
Inventor: Lawrence Blatt

FUSION PROTEINS OF RECOMBINANT SARS CORONAVIRUS STRUCTURAL PROTEINS, THEIR PRODUCTION AND USES Publication number: 20100150923 Abstract: Fusion proteins of recombinant SARS coronavirus structural proteins, their production and uses are provided. An optimized SARS coronavirus S protein gene which can be highly expressed in the mammalian cell strains and SARS coronavirus S protein variants comprising deletion, modification or mutation amino acids 318-510 corresponding to SARS coronavirus S protein are also provided. Type: Application Filed: June 13, 2006 Publication date: June 17, 2010 Applicant: Chinese Academy of Medical Sciences, Institute of Basic Medical Sciences Inventors: Chengyu Jiang, Feng Guo, Shuan Rao, Bing Guan, Yi Huan, Peng Yang

Civet animal model system for Severe Acute Respiratory Syndrome (SARS) coronavirus infection and uses thereof Publication number: 20060123499 Abstract: The present invention is directed towards the use of the masked palm civet Paguma larvata (“civet”)
as an animal model system for SARS, and is based on the novel demonstration of the present invention that civets
may be infected with exogenous coronavirus, and that such infection produces SARS-like symptoms in these infected animals.

The present invention is directed to a civet model system for the study of the infection, replication, and clinical effects of
exogenously introduced human SARS-CoV coronavirus strains, civet SARS-CoV-like coronavirus strains,
or variants or derivatives thereof, and to the development of vaccines (or other methods of prevention)
or treatment of infection or transmission to other civets or humans of these human SARS-CoV coronavirus strains, civet SARS-CoV-like coronavirus strains, or variants or derivatives thereof.
Type: Application
Filed: December 6, 2004 Publication date: June 8, 2006
Inventors: Donglai Wu, Xiangang Kong, Qingwen Meng, Yonggang Liu, Yuntao Guan, Xunnan Yin, Mouping Wang, Changwen Li,
Ming Liao, Chao-an Xin, Jinding Chen, Changchun Tu, Hua Xuan, Yedong Yu

METHODS AND COMPOSITIONS FOR CORONAVIRUS DIAGNOSTICS AND THERAPEUTICS Publication number: 20160238601
Abstract: The present invention provides methods and compositions for detecting a coronavirus in a sample and identifying the subgroup of the coronavirus in the sample. Type: Application Filed: October 14, 2014 Publication date: August 18, 2016
Inventors: Ralph Baric, Sudhakar Agnihothram, Boyd Yount

https://usahitman.com/coronavirus-p...Rmg52BZFAYfjnccQjMyhBVffwlOlF3MDe7NM[/bcolor]